Sensei Biotherapeutics changes name to Faeth Therapeutics

Bayer receives FDA approval for AMBELVIST MRI contrast agent

Johnson & Johnson commits over USD1bn to expand Vision manufacturing in Jacksonville

Genmab reports strong epcoritamab results in elderly newly diagnosed DLBCL patients

AstraZeneca secures US approval for Truqap combination in PTEN‑deficient prostate cancer

Acousia Therapeutics reports positive top-line efficacy results for ACOU085 in cisplatin-induced ototoxicity

Transcend Therapeutics acquired by Otsuka Pharmaceutical

Lilly reports initial clinical data for type II JAK2 inhibitor in patients with previously treated myelofibrosis

Menarini reports Phase 3 data for selinexor plus ruxolitinib in myelofibrosis

Simcere Pharmaceutical and Stanford Medicine agree research collaboration in idiopathic pulmonary fibrosis

ABL Diagnostics secures clinical research contract worth up to EUR2.7m through 2031

WeNatal introduces Iron+ iron and vitamin C supplement

FDA grants priority review for Genentech's Tecentriq in stage III dMMR/MSI-H colon cancer

XtalPi partners with leading biopharma to develop oral small molecule therapeutics for GPCR target

GlycoNex reports positive Phase III trial results for Denosumab biosimilar SPD8